Head-to-head · WeighScore
Direct Meds vs Prime Doctor RX
The verdict
Direct Meds takes it — 77.6/100 to 73/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Direct Meds | Prime Doctor RX |
|---|---|---|
| WeighScore | 77.6/100 | 73/100 |
| Grade | C+ | C |
| Scorecard rank | #36 | #84 |
| Semaglutide | $249/mo sublingual · $297/mo injectable | $249 every 4 weeks (thirteen charges a year, not twelve) |
| Tirzepatide | $299/mo sublingual · $399/mo injectable | $339 every 4 weeks (thirteen charges a year, not twelve) |
| Coverage | Not publicly listed | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #36 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Graded #84 · C
Strengths
- The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
- The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
- The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
- Names OpenLoop Health as the group providing telehealth evaluation and prescribing
- Hormone-care initial labs are priced at $50 rather than left unstated
Where it loses points
- Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
- A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
- The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
- The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
- The $50 lab fee sits in a "how it works" step rather than in the pricing table
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.